Back to top
more

ARK Genomic Revolution ETF: (ARKG)

(Real Time Quote from BATS) As of Nov 19, 2026 01:02 PM ET

$41.08 USD

41.08
2,360,397

-0.18 (-0.44%)

Volume: 2,360,397

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

Zacks News

Sanghamitra Saha headshot

4 Best Investing Areas of Q4 & Their Top ETFs

Despite yearlong COVID-19 fears, Wall Street is ending the fourth quarter on a sweet note.

Sweta Killa headshot

5 Sector ETFs That Beat the Market in 2020

With historic twists and turns, 2020 has turned out to be a banner year.

Neena Mishra headshot

Top ETF Stories of 2020 & Picks for 2021

We discuss the 2020 trends and outlook for 2021...

Sweta Killa headshot

Top ETF of December & Its Best Stocks

We have highlighted the best ETF of December and its best performing stocks.

Sanghamitra Saha headshot

6 Best Active ETFs of 2020

The year 2020 has been beneficial for equities despite coronavirus outbreak. These active ETFs, however, breezed past the benchmark index.

Sweta Killa headshot

8 ETFs That Have Gained More Than 100% in 2020

We have presented a bunch of top-performing ETFs from various corners of the market that gained in triple digits from a year-to-date look and will likely continue outperforming, should the trends prevail.

Sanghamitra Saha headshot

Top Sector ETFs of Record-Setting Last Week

The S&P 500, the Dow Jones and the Nasdaq Composite -- all three indexes touched all-time closing highs to end last week.

Sweta Killa headshot

5 ETFs Deserving Special Thanks in Pandemic-Stricken 2020

We have highlighted five ETFs from different zones that have been star performers so far this year and deserve special thanks and attention going into the New Year.

Sweta Killa headshot

ETFs in Focus on Bayer's Bet on Gene Therapy

Bayer has made a big bet on gene therapy by announcing the acquisition of U.S. biotech firm Asklepios BioPharmaceutical for as much as $4 billion.

Sweta Killa headshot

4 Sector ETFs That Have Doubled This Year

Few sector ETFs have doubled this year amid the coronavirus pandemic.